Does Coffee Kill or Protect?

Results  from the Aerobics Center Longitudinal Study, representing 43,727 participants, shows that coffee consumption was positively associated with death in men who drank more than 28 cups of coffee per week. Based on the results of the study, the study authors conclude that there is a positive link between coffee consumption and death in men and in men and women younger than 55 years. This study seems to suggest that younger people need to avoid heavy coffee consumption. However, the authors also warn that these finding should be assessed in future studies and other populations.

A second, population-based study involving 1,001 prostate cancer survivors aged 35-74 years old at the time of diagnosis between 2002-2005, found that men who drank more than 28 cups of coffee a week ? an average of four cups a day – experienced a 59% reduced risk of prostate cancer recurrence and/or progression as compared to those who drank only one or fewer cups per week. 

Click here to read the article.

For more information:
[1] Liu J, Sui X, Lavie CJ, Hebert JR, Earnest CP, Zhang J, Blair SN. Association of Coffee Consumption With All-Cause and Cardiovascular Disease Mortality. Mayo Clin Proc. 2013 Aug 13. pii: S0025-6196(13)00578-8. doi: 10.1016/j.mayocp.2013.06.020. [Epub ahead of print][Article][PubMed]
[2] Geybels MS, Neuhouser ML, Wright JL, Stott-Miller M, Stanford JL. Coffee and tea consumption in relation to prostate cancer prognosis. Cancer Causes Control. 2013 Aug 2. [Epub ahead of print][Article][PubMed]

Photo 1: Janet Stanford, Ph.D co-director of the Program in Prostate Cancer Research at Fred Hutchinson Cancer Research Center. Photo Courtesy: Fred Hutchinson Cancer Research Center/Susie Fitzhugh.  Photo 2: Coffee Beans.  Photo Courtesy/Copyright: Sumatra Anglo Dutch Plantations of Java, Ltd

Copyright ? 2013 InPress Media Group/Sunvalley Communication. All rights reserved. Republication or redistribution of InPress Media Group/Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group/Sunvalley Communication. InPress Media Group/Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco’Zine and Oncozine are registered trademarks and trademarks of Sunvalley Communication around the world.